Your browser doesn't support javascript.
loading
Modulation of dopamine D1 receptors via histamine H3 receptors is a novel therapeutic target for Huntington's disease.
Moreno-Delgado, David; Puigdellívol, Mar; Moreno, Estefanía; Rodríguez-Ruiz, Mar; Botta, Joaquín; Gasperini, Paola; Chiarlone, Anna; Howell, Lesley A; Scarselli, Marco; Casadó, Vicent; Cortés, Antoni; Ferré, Sergi; Guzmán, Manuel; Lluís, Carmen; Alberch, Jordi; Canela, Enric I; Ginés, Silvia; McCormick, Peter J.
Afiliação
  • Moreno-Delgado D; Department of Biochemistry and Molecular Biomedicine, Faculty of Biology, Institute of Biomedicine of the University of Barcelona (IBUB), University of Barcelona, Barcelona, Spain.
  • Puigdellívol M; Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas, Madrid, Spain.
  • Moreno E; Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas, Madrid, Spain.
  • Rodríguez-Ruiz M; Department of Biomedical Science, Faculty of Medicine, University of Barcelona, Institut of Neuroscience, Barcelona, Spain.
  • Botta J; Institut d´Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
  • Gasperini P; School of Pharmacy, University of East Anglia, Norwich Research Park, Norwich, United Kingdom.
  • Chiarlone A; Department of Biochemistry and Molecular Biomedicine, Faculty of Biology, Institute of Biomedicine of the University of Barcelona (IBUB), University of Barcelona, Barcelona, Spain.
  • Howell LA; Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas, Madrid, Spain.
  • Scarselli M; Department of Biochemistry and Molecular Biomedicine, Faculty of Biology, Institute of Biomedicine of the University of Barcelona (IBUB), University of Barcelona, Barcelona, Spain.
  • Casadó V; Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas, Madrid, Spain.
  • Cortés A; Department of Biochemistry and Molecular Biomedicine, Faculty of Biology, Institute of Biomedicine of the University of Barcelona (IBUB), University of Barcelona, Barcelona, Spain.
  • Ferré S; School of Pharmacy, University of East Anglia, Norwich Research Park, Norwich, United Kingdom.
  • Guzmán M; School of Pharmacy, University of East Anglia, Norwich Research Park, Norwich, United Kingdom.
  • Lluís C; Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas, Madrid, Spain.
  • Alberch J; Department of Biochemistry and Molecular Biology I, School of Biology, Instituto Universitario de Investigación Neuroquímica, and Instituto Ramón y Cajal de Investigación Sanitaria, Complutense University of Madrid, Madrid, Spain.
  • Canela EI; School of Biological and Chemical Sciences, Queen Mary University of London, London, United Kingdom.
  • Ginés S; Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy.
  • McCormick PJ; Department of Biochemistry and Molecular Biomedicine, Faculty of Biology, Institute of Biomedicine of the University of Barcelona (IBUB), University of Barcelona, Barcelona, Spain.
Elife ; 92020 06 09.
Article em En | MEDLINE | ID: mdl-32513388
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Sistemas de Liberação de Medicamentos / Receptores de Dopamina D1 / Doença de Huntington / Receptores Histamínicos H3 Limite: Animals / Female / Humans / Male Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Sistemas de Liberação de Medicamentos / Receptores de Dopamina D1 / Doença de Huntington / Receptores Histamínicos H3 Limite: Animals / Female / Humans / Male Idioma: En Ano de publicação: 2020 Tipo de documento: Article